Clinician-trialist rounds: 6. Testing for blindness at the end of your trial is a mug's game.
Irish Lake, RR 1, Markdale, Ontario, Canada, N0C 1H0. sackett@bmts.com
David L
DL
Sackett
D001241:Aspirin / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D012107:Research Design; D012108:Research Personnel; D020521:Stroke / Q000517:prevention & control
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin